全文获取类型
收费全文 | 52318篇 |
免费 | 4339篇 |
国内免费 | 1202篇 |
专业分类
耳鼻咽喉 | 29225篇 |
儿科学 | 814篇 |
妇产科学 | 231篇 |
基础医学 | 3277篇 |
口腔科学 | 1871篇 |
临床医学 | 1890篇 |
内科学 | 2626篇 |
皮肤病学 | 326篇 |
神经病学 | 1907篇 |
特种医学 | 898篇 |
外国民族医学 | 2篇 |
外科学 | 6938篇 |
综合类 | 2400篇 |
现状与发展 | 2篇 |
一般理论 | 5篇 |
预防医学 | 613篇 |
眼科学 | 359篇 |
药学 | 961篇 |
26篇 | |
中国医学 | 80篇 |
肿瘤学 | 3408篇 |
出版年
2024年 | 47篇 |
2023年 | 1062篇 |
2022年 | 1563篇 |
2021年 | 1926篇 |
2020年 | 2155篇 |
2019年 | 1239篇 |
2018年 | 1916篇 |
2017年 | 1595篇 |
2016年 | 2236篇 |
2015年 | 2219篇 |
2014年 | 3723篇 |
2013年 | 2913篇 |
2012年 | 2775篇 |
2011年 | 2713篇 |
2010年 | 2459篇 |
2009年 | 2372篇 |
2008年 | 2046篇 |
2007年 | 2212篇 |
2006年 | 2112篇 |
2005年 | 1723篇 |
2004年 | 1736篇 |
2003年 | 1696篇 |
2002年 | 1550篇 |
2001年 | 1494篇 |
2000年 | 1467篇 |
1999年 | 1506篇 |
1998年 | 444篇 |
1997年 | 357篇 |
1996年 | 287篇 |
1995年 | 221篇 |
1994年 | 191篇 |
1993年 | 158篇 |
1992年 | 917篇 |
1991年 | 982篇 |
1990年 | 939篇 |
1989年 | 795篇 |
1988年 | 668篇 |
1987年 | 364篇 |
1986年 | 89篇 |
1985年 | 147篇 |
1984年 | 135篇 |
1983年 | 64篇 |
1982年 | 98篇 |
1981年 | 72篇 |
1980年 | 75篇 |
1979年 | 71篇 |
1978年 | 55篇 |
1977年 | 45篇 |
1976年 | 38篇 |
1975年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《American journal of otolaryngology》2022,43(4):103482
BackgroundAlthough there are many treatments for laryngeal contact granuloma (LCG), some patients still fail treatment. Botulinum toxin A injection vocal cords may be a salvage therapy.ObjectivesTo study the efficacy of thyroarytenoid botulinum toxin A injection for the treatment of refractory LCG.Material and methodsFrom May 2021 to March 2022, 23 male patients with refractory idiopathic LCG were treated by injection of botulinum toxin A into the thyroarytenoid muscle via the thyrohyoid membrane approach. Inspiratory-phase laryngoscopy images were collected before treatment and 3 months after injection treatment. The lesion size was evaluated with the Farwell granuloma endoscopic grading system and Image J software.ResultsThe average age of 23 patients was 49 years. The dose of botulinum toxin injection ranged from 2.5 to 5 units. Three months after injection, 17 patients were cured, 2 patients showed marked improvement, and 4 patients did not experience any effect. The total efficacy rate was 82.61% (19/23), and no serious complications occurred. Almost all patients experienced hoarseness within one week after injection; they gradually recovered after one month, and their voice returned to baseline at 3 months.ConclusionsThyroarytenoid botulinum toxin injection is an effective method for resolving refractory LCG. 相似文献
3.
4.
《Survey of ophthalmology》2023,68(2):257-264
RationaleObstructive sleep apnoea (OSA) has been linked to various ocular disorders, including floppy eyelid syndrome (FES). Previous studies have hypothesised the underlying association between the 2 , but results are currently still inconclusive.ObjectiveTo investigate the association between OSA and FES.MethodsFour databases (Pubmed, Embase, Scopus, and Cochrane Library) were searched from inception until 28 February 2022 for observational studies and randomized controlled trials assessing the association between OSA and FES. Two reviewers selected studies, extracted data, graded the risk of bias using the Newcastle-Ottawa scale and the quality of assessment using the Grading of Recommendations Assessment, Development, and Evaluation system. Random-effects models were used to metaanalyze the associations.ResultsTwelve studies were included in the systematic review, of which nine were suitable for metaanalysis, with a combined cohort of 1,109 patients. Risk of bias was low to moderate. The overall analysis showed a significant positive association between OSA and FES (OR = 1.89, 95% CI = 1.27–2.83, I 2 = 44%). Further analysis revealed that the more severe the OSA was, the higher the risk of developing FES. Patients with severe OSA had the nominally highest risk of developing FES (OR = 3.06, 95% CI = 1.62–5.78, I 2 = 0%), followed by moderate OSA (OR = 2.53, 95% CI = 1.29–4.97, I 2 = 0%), and patients with mild OSA had the lowest risk (OR = 1.76, 95% CI = 0.85–3.62, I 2 = 0%).ConclusionOur metaanalysis reports a positive association between OSA and FES, with increasing severity of OSA correlating with a significantly higher risk of FES. More longitudinal studies with sufficient duration of follow-up are needed to better characterise the relationship between OSA and FES. 相似文献
5.
6.
7.
8.
9.
ObjectivesMap regional lymph node metastases for lateralized oral cavity squamous cell carcinoma (OCSCC) and evaluate factors associated with regional metastases and recurrence.Materials and methodsRetrospective cohort study of 715 patients with lateralized OCSCC surgically treated in 1997–2011. Analysis was performed using log-rank, Kaplan-Meier, and multivariable logistic and Cox regression.ResultsRegional metastases were identified in ipsilateral levels IIA (24%), IB (18%), III (13%), V (9%), IV (7%), IA (2%) and IIB (1%) and the contralateral neck (3%). Lymphovascular invasion (LVI) (Hazard Ratio [HR] 2.2, 95% Confidence Interval [CI] 1.2–3.9) and T category (T3 vs. T1: HR 4.1, 95% CI 1.9–9.3; T4 vs. T1: HR 2.3, 95% CI 1.2–4.3) were associated with regional metastases. Most (71%) isolated regional metastatic recurrences were in undissected levels of the neck, including 58% in levels IV and V. Tumors of the hard palate (HR 4.3, 95% CI 1.2–16.1), upper alveolus (HR 3.2, 95% CI 1.0–4.7) or with LVI (HR 2.0, 95% CI 1.0–3.9) were associated with isolated regional recurrence. For upper alveolar/hard palate tumors, depth of invasion (DOI) ≥4 mm (P = .003) and LVI (P = .04) were associated with regional metastases.ConclusionsFor lateralized OCSCC, elective neck dissection of level IIB or the contralateral neck may rarely be needed, but additional surgical or radiation treatment of levels IV and V may be considered based on patient risk factors, including T category 3–4 or LVI. For upper alveolar/hard palate tumors, DOI ≥4 mm is an appropriate threshold for elective neck dissection. 相似文献
10.